Tier Seven identifies biomedical technologies that can improve the delivery of health care for our active duty personnel, veterans, and their families.


Proven DoD Strategic Roadmaps.
Proven support.
Proven results.


Cooperative R&D Agreements (CRADAs)

Consulting Services

Science Advisory Services




In 2015, over $2.6M in non-dilutive and dilutive funding awards

In 2016, clients were awarded $4.5M in non-dilutive funding


In 2015, 75% of full application DoD non-dilutive submissions received awards



$1.5M in CRADA value for the DoD and Industry


Dr. Hanson was instrumental in Sonivate Medical receiving $2.5 million in funding from the US Army to develop an ultrasound system focused on emergency medicine including the forward deployment. He guided us through the whole proposal process and especially ensured that we included the Training Development and the Assessments for the medics. As it turned out, the Assessments were vital documents in our 510k submission to the FDA to establish a predicate product. Eric’s sections in the proposal received Sonivate’s highest ratings.

Thanks to Dr. Hanson, and most recently the FDA clearance, we are now well on our way to offer this needed product to our military and emergency medicine worldwide.

James Hatlan, President and CEO, Sonivate Medical, Inc.